June 17, 2013
American Lawyer | Subscription Required | June 17, 2013
Pfizer Inc. got some rare good news out of Alabama on Thursday, when the state's high court agreed to revisit its controversial ruling that brand-name drug companies can be held liable for injuries caused by generic versions of their drugs manufactured by third parties.
June 14, 2013
ThomsonReuters | June 14, 2013
The Alabama Supreme Court on Thursday agreed to reconsider arguments over whether a brand-name drug company can be held liable for injuries allegedly caused by a competitor's product.
WSJ.com Law Blog | June 14, 2013
Alabama’s Supreme Court will reconsider a controversial ruling that name-brand drug makers can be held liable for injuries caused by products they didn’t make.
March 29, 2013
Legal Newsline | March 29, 2013
The Kentucky Supreme Court ruled in a decision published this month that an arbitration agreement, which provides it is controlled by the Federal Arbitration Act, is enforceable in state courts.
March 14, 2013
Wall Street Journal | Subscription Required | March 14, 2013
Can a drug company be held liable for damages caused by generic drugs it didn't produce? That's the expansive new theory of "innovator liability" on parade in Alabama, where a recent ruling by the state Supreme Court could do damage throughout the U.S. economy.
February 26, 2013
AL.com | February 26, 2013
Legislation that would help protect Airbus from lawsuits resulting from accidents involving planes built at the new plant in Mobile is riding a fast track in the Alabama Legislature.
February 25, 2013
Wall Street Journal | Subscription Required | February 25, 2013
Business groups are urging Alabama's highest court to reconsider its recent ruling that name-brand drug makers can be held liable for injuries caused by the generic versions of their products.
February 20, 2013
American Lawyer | Subscription Required | February 20, 2013
Brand-name drug companies have launched a last-ditch effort to undo a state court's ruling that they are liable for injuries caused by generic drugs they didn't manufacture.
January 14, 2013
New York Times | January 14, 2013
The Alabama Supreme Court ruled on Friday that a patient could sue a brand-name company for failing to warn about a drug’s risks even though he had taken a generic version of the product that the company did not make.
November 19, 2012
Bloomberg | November 19, 2012
Pfizer Inc.’s top executive must testify in court about claims the company’s anti-smoking drug Chantix causes depression and other psychiatric disorders, a lawyer for an Alabama man suing over the medication said.
- News by Issue
- Arbitration & ADR
- Class Action
- Environmental Litigation
- Financial Services
- Foreign Corrupt Practices Act
- Government Contracts & Whistleblower Legislation
- Lawsuit Abuse Impact
- Legal Ethics
- Medical Liability
- Securities Litigation
- State Attorneys General
- Third-Party Litigation Financing
- Trial Lawyers' Influence
- News by State
- New Hampshire
- New Jersey
- New Mexico
- New York
- North Carolina
- North Dakota
- Rhode Island
- South Carolina
- South Dakota
- West Virginia
- ILR in the News
From The Blog
WASHINGTON, D.C.—Lisa A. Rickard, president of the U.S. Chamber Institute for Legal Reform (ILR), made the following...
Yesterday, the Nevada Supreme Court heard a challenge involving a case that could tank $127 million worth of...
Please finish this lead sentence in a May 9 story in the Louisiana Record: “A New Orleans woman who was allegedly...